Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Bianchi, M. C. Articles by Siciliano, G. Search for Related Content PubMed PubMed Citation Articles by Bianchi, M. C. Articles by Siciliano, G.

American Journal of Neuroradiology 24:1958-1966, November-December 2003
© 2003 American Society of Neuroradiology

BRAIN

Proton MR Spectroscopy of Mitochondrial Diseases: Analysis of Brain Metabolic Abnormalities and Their Possible Diagnostic Relevance

M. Cristina Bianchi^a,b, Michela Tosetti^b, Roberta Battini^b, Maria L. Manca^c, Michelangelo Mancuso^c, Giovanni Cioni^b,d, Raffaello Canapicchi^b and Gabriele Siciliano^c

^a U.O. di Neuroradiologia, Ospedale S. Chiara, Pisa, Italy
^b Istituto Scientifico Stella Maris, Pisa, Italy
^c Dipartimento di Neurologia, Università di Pisa, Italy
^d Divisione di Neuropsichiatria Infantile, Università di Pisa, Italy

Address reprint requests to M.C. Bianchi, MD, U.O. di Neuroradiologia, Ospedale S. Chiara, Pisa, Via Roma 67, 56100 Pisa, Italy

BACKGROUND AND PURPOSE: Proton (hydrogen-1 [¹H]) MR spectroscopy is a useful diagnostic tool in many metabolic diseases, but only scattered and inconclusive data are available on mitochondrial diseases. We performed MR imaging and ¹H MR spectroscopy of the brain in patients with different types of primary mitochondrial diseases to investigate the role of ¹H MR spectroscopy in the clinical evaluation of these disorders.

METHODS: In 15 patients (11 adults, four children) with mitochondrial diseases, localized MR spectra were obtained at short TEs in cerebellar white matter, paratrigonal white matter, and parieto-occipital cortex that appeared normal on MR images. Additional spectra of basal ganglia and cortical gray matter structural lesions were obtained in three patients.

RESULTS: A significant choline reduction and N-acetylaspartate reduction were found in areas that appeared normal on MR images. Lactate was never found in areas that appeared normal on MR images, except in two children in whom MR studies were performed during episodes of symptom exacerbation and revealed elevated lactate both in areas that appeared damaged on MR images and in normal-appearing areas. An additional abnormal signal at 0.9 ppm was found in a consistent number of studies.

CONCLUSION: ¹H MR spectroscopy proved to be a useful investigational tool for mitochondrial diseases, as it enabled detection of metabolic abnormalities even in areas of brain that appeared normal on MR images, especially when it was performed during episodes of clinical relapses or clinical exacerbation.

This article has been cited by other articles:

				R. H. Haas, S. Parikh, M. J. Falk, R. P. Saneto, N. I. Wolf, N. Darin, and B. H. Cohen Mitochondrial Disease: A Practical Approach for Primary Care Physicians Pediatrics, December 1, 2007; 120(6): 1326 - 1333. [Abstract] [Full Text] [PDF]

				L. Vedolin, I.V.D. Schwartz, M. Komlos, A. Schuch, A.C. Puga, L.L.C. Pinto, A.P. Pires, and R. Giugliani Correlation of MR Imaging and MR Spectroscopy Findings with Cognitive Impairment in Mucopolysaccharidosis II AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1029 - 1033. [Abstract] [Full Text] [PDF]

				M. Mascalchi, D. De Grandis, A. Ginestroni, A. Pratesi, R. D. Nave, G. C. Scheper, and M. S. van der Knaap Early MR imaging and spectroscopy appearance of eIF2B-related leukoencephalopathy Neurology, August 8, 2006; 67(3): 537 - 538. [Full Text] [PDF]